Global Lower GI Series Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 80673
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Lower GI Series market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Lower GI Series size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Lower GI Series market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Lower GI Series market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Double-Contrast

Single-Contrast

Market segment by Application, can be divided into

Hospital

Clinic

Other

Market segment by players, this report covers

Eisai

Cadila Pharmaceuticals

Purdue Pharma

Peacehealth

Novadaq

Astrazeneca

Ironwood Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Lower GI Series product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Lower GI Series, with revenue, gross margin and global market share of Lower GI Series from 2019 to 2021.

Chapter 3, the Lower GI Series competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Lower GI Series market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Lower GI Series research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Lower GI Series

1.2 Classification of Lower GI Series by Type

1.2.1 Overview: Global Lower GI Series Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Lower GI Series Revenue Market Share by Type in 2020

1.2.3 Double-Contrast

1.2.4 Single-Contrast

1.3 Global Lower GI Series Market by Application

1.3.1 Overview: Global Lower GI Series Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Lower GI Series Market Size & Forecast

1.5 Global Lower GI Series Market Size and Forecast by Region

1.5.1 Global Lower GI Series Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Lower GI Series Market Size by Region, (2016-2021)

1.5.3 North America Lower GI Series Market Size and Prospect (2016-2026)

1.5.4 Europe Lower GI Series Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Lower GI Series Market Size and Prospect (2016-2026)

1.5.6 South America Lower GI Series Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Lower GI Series Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Lower GI Series Market Drivers

1.6.2 Lower GI Series Market Restraints

1.6.3 Lower GI Series Trends Analysis

2 Company Profiles

2.1 Eisai

2.1.1 Eisai Details

2.1.2 Eisai Major Business

2.1.3 Eisai Lower GI Series Product and Solutions

2.1.4 Eisai Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Eisai Recent Developments and Future Plans

2.2 Cadila Pharmaceuticals

2.2.1 Cadila Pharmaceuticals Details

2.2.2 Cadila Pharmaceuticals Major Business

2.2.3 Cadila Pharmaceuticals Lower GI Series Product and Solutions

2.2.4 Cadila Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Cadila Pharmaceuticals Recent Developments and Future Plans

2.3 Purdue Pharma

2.3.1 Purdue Pharma Details

2.3.2 Purdue Pharma Major Business

2.3.3 Purdue Pharma Lower GI Series Product and Solutions

2.3.4 Purdue Pharma Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Purdue Pharma Recent Developments and Future Plans

2.4 Peacehealth

2.4.1 Peacehealth Details

2.4.2 Peacehealth Major Business

2.4.3 Peacehealth Lower GI Series Product and Solutions

2.4.4 Peacehealth Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Peacehealth Recent Developments and Future Plans

2.5 Novadaq

2.5.1 Novadaq Details

2.5.2 Novadaq Major Business

2.5.3 Novadaq Lower GI Series Product and Solutions

2.5.4 Novadaq Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Novadaq Recent Developments and Future Plans

2.6 Astrazeneca

2.6.1 Astrazeneca Details

2.6.2 Astrazeneca Major Business

2.6.3 Astrazeneca Lower GI Series Product and Solutions

2.6.4 Astrazeneca Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Astrazeneca Recent Developments and Future Plans

2.7 Ironwood Pharmaceuticals

2.7.1 Ironwood Pharmaceuticals Details

2.7.2 Ironwood Pharmaceuticals Major Business

2.7.3 Ironwood Pharmaceuticals Lower GI Series Product and Solutions

2.7.4 Ironwood Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Ironwood Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Lower GI Series Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Lower GI Series Players Market Share

3.2.2 Top 10 Lower GI Series Players Market Share

3.2.3 Market Competition Trend

3.3 Lower GI Series Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Lower GI Series Revenue and Market Share by Type (2016-2021)

4.2 Global Lower GI Series Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Lower GI Series Revenue Market Share by Application (2016-2021)

5.2 Lower GI Series Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Lower GI Series Revenue by Type (2016-2026)

6.2 North America Lower GI Series Revenue by Application (2016-2026)

6.3 North America Lower GI Series Market Size by Country

6.3.1 North America Lower GI Series Revenue by Country (2016-2026)

6.3.2 United States Lower GI Series Market Size and Forecast (2016-2026)

6.3.3 Canada Lower GI Series Market Size and Forecast (2016-2026)

6.3.4 Mexico Lower GI Series Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Lower GI Series Revenue by Type (2016-2026)

7.2 Europe Lower GI Series Revenue by Application (2016-2026)

7.3 Europe Lower GI Series Market Size by Country

7.3.1 Europe Lower GI Series Revenue by Country (2016-2026)

7.3.2 Germany Lower GI Series Market Size and Forecast (2016-2026)

7.3.3 France Lower GI Series Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Lower GI Series Market Size and Forecast (2016-2026)

7.3.5 Russia Lower GI Series Market Size and Forecast (2016-2026)

7.3.6 Italy Lower GI Series Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Lower GI Series Revenue by Type (2016-2026)

8.2 Asia-Pacific Lower GI Series Revenue by Application (2016-2026)

8.3 Asia-Pacific Lower GI Series Market Size by Region

8.3.1 Asia-Pacific Lower GI Series Revenue by Region (2016-2026)

8.3.2 China Lower GI Series Market Size and Forecast (2016-2026)

8.3.3 Japan Lower GI Series Market Size and Forecast (2016-2026)

8.3.4 South Korea Lower GI Series Market Size and Forecast (2016-2026)

8.3.5 India Lower GI Series Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Lower GI Series Market Size and Forecast (2016-2026)

8.3.7 Australia Lower GI Series Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Lower GI Series Revenue by Type (2016-2026)

9.2 South America Lower GI Series Revenue by Application (2016-2026)

9.3 South America Lower GI Series Market Size by Country

9.3.1 South America Lower GI Series Revenue by Country (2016-2026)

9.3.2 Brazil Lower GI Series Market Size and Forecast (2016-2026)

9.3.3 Argentina Lower GI Series Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Lower GI Series Revenue by Type (2016-2026)

10.2 Middle East & Africa Lower GI Series Revenue by Application (2016-2026)

10.3 Middle East & Africa Lower GI Series Market Size by Country

10.3.1 Middle East & Africa Lower GI Series Revenue by Country (2016-2026)

10.3.2 Turkey Lower GI Series Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Lower GI Series Market Size and Forecast (2016-2026)

10.3.4 UAE Lower GI Series Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Lower GI Series Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Lower GI Series Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Lower GI Series Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Lower GI Series Revenue (USD Million) by Region (2016-2021)

Table 5. Global Lower GI Series Revenue Market Share by Region (2021-2026)

Table 6. Eisai Corporate Information, Head Office, and Major Competitors

Table 7. Eisai Major Business

Table 8. Eisai Lower GI Series Product and Solutions

Table 9. Eisai Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Cadila Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Cadila Pharmaceuticals Major Business

Table 12. Cadila Pharmaceuticals Lower GI Series Product and Solutions

Table 13. Cadila Pharmaceuticals Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Purdue Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Purdue Pharma Major Business

Table 16. Purdue Pharma Lower GI Series Product and Solutions

Table 17. Purdue Pharma Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Peacehealth Corporate Information, Head Office, and Major Competitors

Table 19. Peacehealth Major Business

Table 20. Peacehealth Lower GI Series Product and Solutions

Table 21. Peacehealth Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Novadaq Corporate Information, Head Office, and Major Competitors

Table 23. Novadaq Major Business

Table 24. Novadaq Lower GI Series Product and Solutions

Table 25. Novadaq Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Astrazeneca Corporate Information, Head Office, and Major Competitors

Table 27. Astrazeneca Major Business

Table 28. Astrazeneca Lower GI Series Product and Solutions

Table 29. Astrazeneca Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Ironwood Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 31. Ironwood Pharmaceuticals Major Business

Table 32. Ironwood Pharmaceuticals Lower GI Series Product and Solutions

Table 33. Ironwood Pharmaceuticals Lower GI Series Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Global Lower GI Series Revenue (USD Million) by Players (2019-2021)

Table 35. Global Lower GI Series Revenue Share by Players (2019-2021)

Table 36. Breakdown of Lower GI Series by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. Lower GI Series Players Head Office, Products and Services Provided

Table 38. Lower GI Series Mergers & Acquisitions in the Past Five Years

Table 39. Lower GI Series New Entrants and Expansion Plans

Table 40. Global Lower GI Series Revenue (USD Million) by Type (2016-2021)

Table 41. Global Lower GI Series Revenue Share by Type (2016-2021)

Table 42. Global Lower GI Series Revenue Forecast by Type (2021-2026)

Table 43. Global Lower GI Series Revenue by Application (2016-2021)

Table 44. Global Lower GI Series Revenue Forecast by Application (2021-2026)

Table 45. North America Lower GI Series Revenue by Type (2016-2021) & (USD Million)

Table 46. North America Lower GI Series Revenue by Type (2021-2026) & (USD Million)

Table 47. North America Lower GI Series Revenue by Application (2016-2021) & (USD Million)

Table 48. North America Lower GI Series Revenue by Application (2021-2026) & (USD Million)

Table 49. North America Lower GI Series Revenue by Country (2016-2021) & (USD Million)

Table 50. North America Lower GI Series Revenue by Country (2021-2026) & (USD Million)

Table 51. Europe Lower GI Series Revenue by Type (2016-2021) & (USD Million)

Table 52. Europe Lower GI Series Revenue by Type (2021-2026) & (USD Million)

Table 53. Europe Lower GI Series Revenue by Application (2016-2021) & (USD Million)

Table 54. Europe Lower GI Series Revenue by Application (2021-2026) & (USD Million)

Table 55. Europe Lower GI Series Revenue by Country (2016-2021) & (USD Million)

Table 56. Europe Lower GI Series Revenue by Country (2021-2026) & (USD Million)

Table 57. Asia-Pacific Lower GI Series Revenue by Type (2016-2021) & (USD Million)

Table 58. Asia-Pacific Lower GI Series Revenue by Type (2021-2026) & (USD Million)

Table 59. Asia-Pacific Lower GI Series Revenue by Application (2016-2021) & (USD Million)

Table 60. Asia-Pacific Lower GI Series Revenue by Application (2021-2026) & (USD Million)

Table 61. Asia-Pacific Lower GI Series Revenue by Region (2016-2021) & (USD Million)

Table 62. Asia-Pacific Lower GI Series Revenue by Region (2021-2026) & (USD Million)

Table 63. South America Lower GI Series Revenue by Type (2016-2021) & (USD Million)

Table 64. South America Lower GI Series Revenue by Type (2021-2026) & (USD Million)

Table 65. South America Lower GI Series Revenue by Application (2016-2021) & (USD Million)

Table 66. South America Lower GI Series Revenue by Application (2021-2026) & (USD Million)

Table 67. South America Lower GI Series Revenue by Country (2016-2021) & (USD Million)

Table 68. South America Lower GI Series Revenue by Country (2021-2026) & (USD Million)

Table 69. Middle East & Africa Lower GI Series Revenue by Type (2016-2021) & (USD Million)

Table 70. Middle East & Africa Lower GI Series Revenue by Type (2021-2026) & (USD Million)

Table 71. Middle East & Africa Lower GI Series Revenue by Application (2016-2021) & (USD Million)

Table 72. Middle East & Africa Lower GI Series Revenue by Application (2021-2026) & (USD Million)

Table 73. Middle East & Africa Lower GI Series Revenue by Country (2016-2021) & (USD Million)

Table 74. Middle East & Africa Lower GI Series Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Lower GI Series Picture

Figure 2. Global Lower GI Series Revenue Market Share by Type in 2020

Figure 3. Double-Contrast

Figure 4. Single-Contrast

Figure 5. Lower GI Series Revenue Market Share by Application in 2020

Figure 6. Hospital Picture

Figure 7. Clinic Picture

Figure 8. Other Picture

Figure 9. Global Lower GI Series Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Lower GI Series Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Lower GI Series Revenue Market Share by Region (2016-2026)

Figure 12. Global Lower GI Series Revenue Market Share by Region in 2020

Figure 13. North America Lower GI Series Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Lower GI Series Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Lower GI Series Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Lower GI Series Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Lower GI Series Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Lower GI Series Market Drivers

Figure 19. Lower GI Series Market Restraints

Figure 20. Lower GI Series Market Trends

Figure 21. Eisai Recent Developments and Future Plans

Figure 22. Cadila Pharmaceuticals Recent Developments and Future Plans

Figure 23. Purdue Pharma Recent Developments and Future Plans

Figure 24. Peacehealth Recent Developments and Future Plans

Figure 25. Novadaq Recent Developments and Future Plans

Figure 26. Astrazeneca Recent Developments and Future Plans

Figure 27. Ironwood Pharmaceuticals Recent Developments and Future Plans

Figure 28. Global Lower GI Series Revenue Share by Players in 2020

Figure 29. Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 30. Global Top 3 Players Lower GI Series Revenue Market Share in 2020

Figure 31. Global Top 10 Players Lower GI Series Revenue Market Share in 2020

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 33. Global Lower GI Series Revenue Share by Type in 2020

Figure 34. Global Lower GI Series Market Share Forecast by Type (2021-2026)

Figure 35. Global Lower GI Series Revenue Share by Application in 2020

Figure 36. Global Lower GI Series Market Share Forecast by Application (2021-2026)

Figure 37. North America Lower GI Series Sales Market Share by Type (2016-2026)

Figure 38. North America Lower GI Series Sales Market Share by Application (2016-2026)

Figure 39. North America Lower GI Series Revenue Market Share by Country (2016-2026)

Figure 40. United States Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Lower GI Series Sales Market Share by Type (2016-2026)

Figure 44. Europe Lower GI Series Sales Market Share by Application (2016-2026)

Figure 45. Europe Lower GI Series Revenue Market Share by Country (2016-2026)

Figure 46. Germany Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Lower GI Series Sales Market Share by Type (2016-2026)

Figure 52. Asia-Pacific Lower GI Series Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Lower GI Series Revenue Market Share by Region (2016-2026)

Figure 54. China Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Japan Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. South Korea Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. India Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Southeast Asia Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Australia Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South America Lower GI Series Sales Market Share by Type (2016-2026)

Figure 61. South America Lower GI Series Sales Market Share by Application (2016-2026)

Figure 62. South America Lower GI Series Revenue Market Share by Country (2016-2026)

Figure 63. Brazil Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Argentina Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Middle East and Africa Lower GI Series Sales Market Share by Type (2016-2026)

Figure 66. Middle East and Africa Lower GI Series Sales Market Share by Application (2016-2026)

Figure 67. Middle East and Africa Lower GI Series Revenue Market Share by Country (2016-2026)

Figure 68. Turkey Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Saudi Arabia Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. UAE Lower GI Series Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz